Thyrocare Technologies Declares 2:1 Bonus Issue: Shareholders to Get 200 Shares for Every 100 Held

Thyrocare Technologies Limited, a leading diagnostic services provider, has announced multiple shareholder-friendly measures as part of its 25th anniversary celebrations. These include a 2:1 bonus share issue, an interim dividend, and strong Q2 financial results, highlighting the company’s healthy performance and growth outlook. 

Thyrocare Q2FY26 Earnings Results

For the quarter ended September 30, Thyrocare reported a solid set of numbers, reinforcing its leadership in the diagnostics space.

The results reflect consistent demand for diagnostic services and operational efficiency across the company’s nationwide network.

Details of Thyrocare Technologies 2:1 Bonus Share Issue

The Board of Directors has approved a bonus issue in the ratio of 2:1, meaning shareholders will receive two new shares for every one share held, subject to shareholder approval.

 This move aims to enhance share liquidity and reward long-term investors. The record date for determining eligible shareholders will be announced later.

Interim Dividend of ₹7 per Share

Along with the bonus issue, Thyrocare has declared an interim dividend of Rs 7 per equity share, equivalent to 70% of the face value. The record date for this dividend is October 24, 2025.

Other Key Updates

• Increase in Authorized Share Capital: From ₹100 crore to ₹300 crore to support the upcoming bonus issue.
• Employee Stock Options: Allotment of 59,450 equity shares under the company’s ESOP plan.
• Auditor Reappointment:Ernst & Young reappointed as internal auditors, ensuring continued transparency and governance.

Thyrocare Tech Share Price Performance

Thyrocare Tech share price has delivered robust returns, rising over 77% in the past six months and 54% in the last year, reflecting strong investor confidence.

Read more: Dividends & Bonus Issue This Week (October 13-17, 2025): TCS, Anand Rathi, Tata Investment Corp, and More.

Conclusion

Thyrocare’s 2:1 bonus issue and interim dividend come as a celebratory gesture for its 25th year, reaffirming its commitment to shareholder value. With strong financials and expanding market reach, the company continues to be a standout performer in India’s diagnostics industry.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.